IL-5-dependent conversion of normodense human eosinophils to the hypodense phenotype uses 3T3 fibroblasts for enhanced viability, accelerated hypodensity, and sustained antibody-dependent cytotoxicity.
Open Access
- 1 October 1989
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 143 (7) , 2311-2316
- https://doi.org/10.4049/jimmunol.143.7.2311
Abstract
Human peripheral blood-derived eosinophils were assessed for their viability, density, and functional properties after 7 days of culture with purified mouse IL-5 and mouse 3T3 fibroblasts. Whereas none of the eosinophils remained viable after 7 days of culture in the absence of IL-5, 38 +/- 12% and 61 +/- 14% (n = 6, mean +/- SD) of the eosinophils survived in the presence of 1 pM IL-5 alone or 1 pM IL-5 in the presence of 3T3 fibroblasts, respectively (p less than 0.05). Direct contact between the fibroblasts and the eosinophils was not needed for this enhanced IL-5-dependent viability. After 7 days, 66 +/- 7% (n = 6) of the cocultured eosinophils were viable when the two cell types were separated by a 0.4-microns filter. As assessed by density-gradient centrifugation after 7 days of IL-5 exposure, all of the original normodense eosinophils became hypodense. The time course of this conversion was accelerated by the presence of 3T3 fibroblasts. Enhanced helminthic cytotoxicity was maintained by the 7-day cultured eosinophils only if they had been cocultured with fibroblasts. Eosinophils killed 10 +/- 11% (n = 5), 48 +/- 17%, and 31 +/- 15% of the larvae when they were cultured for 7 days in IL-5 alone, in IL-5 in direct contact with 3T3 fibroblasts, or in IL-5 with filter separation of the fibroblasts and the eosinophils, respectively. The ability of IL-5 to induce progenitor cells to differentiate selectively into eosinophils, and of 3T3 fibroblasts to facilitate the IL-5-mediated conversion of normodense eosinophils to hypodense eosinophils with increased viability and antibody-dependent cytotoxicity suggests a role for both hematopoietic and tissue factors in determining the presence and pathobiologic function of activated hypodense eosinophils in patients with hypereosinophilic conditions.This publication has 16 references indexed in Scilit:
- Synthesis and release of leukotriene C4 by human eosinophils.The Journal of Immunology, 1987
- Enhancement of human eosinophil cytotoxicity and leukotriene synthesis by biosynthetic (recombinant) granulocyte-macrophage colony-stimulating factor.The Journal of Immunology, 1986
- Murine eosinophil differentiation factor. An eosinophil-specific colony-stimulating factor with activity for human cells.The Journal of Experimental Medicine, 1986
- INCREASED NUMBERS OF HYPODENSE EOSINOPHILS IN THE BLOOD OF PATIENTS WITH BRONCHIAL-ASTHMAPublished by Elsevier ,1985
- Release of Leukotriene C4 from Human Eosinophils and its Relation to the Cell DensityInternational Archives of Allergy and Immunology, 1985
- HETEROGENEITY OF HUMAN EOSINOPHILS .2. VARIABILITY OF RESPIRATORY BURST ACTIVITY RELATED TO CELL-DENSITY1984
- Maturation In Vivo of Schistosoma mansoni Schistosomula After Culture In Vitro with Granulocytes and AntibodyInfection and Immunity, 1983
- Heterogeneity of Human Peripheral Blood Eosinophils: Variability in Cell Density and Cytotoxic Ability in Relation to the Level and the Origin of HypereosinophiliaInternational Archives of Allergy and Immunology, 1983
- ALTERED DENSITY, METABOLISM AND SURFACE-RECEPTORS OF EOSINOPHILS IN EOSINOPHILIA1982
- A New Method for the Purification of Human Eosinophils and Neutrophils, and a Comparison of the Ability of These Cells to Damage Schistosomula of Schistosoma MansoniThe Journal of Immunology, 1979